VBI Vaccines Announces $2M Registered Direct Offering At $0.88/Share
Portfolio Pulse from Benzinga Newsdesk
VBI Vaccines has announced a registered direct offering of $2 million worth of shares priced at $0.88 each. This move is aimed at raising capital, potentially for further research, development, or operational expenses.
April 09, 2024 | 6:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
VBI Vaccines' direct offering at $0.88/share aims to raise $2 million, potentially affecting its stock price due to the dilution of existing shares.
Direct offerings often lead to dilution of existing shares, which can negatively impact the stock price in the short term. Investors may view this move as necessary for growth but are typically cautious about dilution effects.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100